Press Release Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study 4 November 2023
Press Release Maze Therapeutics Highlights New Preclinical Data Supporting Advancement of APOL1 Inhibitor Candidate Toward Clinical Evaluation for APOL1 Kidney Disease 4 November 2023
Press Release Priority One Logistics LLC Expands into Residential Moving Market with Acquisition of “Everything Goes Movers” 4 November 2023
Press Release NATERA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Natera, Inc. – NTRA 4 November 2023
Press Release TANDEM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm 4 November 2023
Press Release LESLIE’S DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Leslie’s, Inc. and Encourages Investors to Contact the Firm 4 November 2023
Press Release UIPATH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against UiPath, Inc. and Encourages Investors to Contact the Firm 4 November 2023
Press Release BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm 4 November 2023
